Reagent Kit for Simultaneous Detection and Quantification of DNA from Ureaplasma parvum, Ureaplasma urealyticum, and Mycoplasma hominis in Clinical Samples by PCR with Hybridization-Fluorescent Detection

Reagent Kit for Simultaneous Detection and Quantification of DNA from Ureaplasma parvum, Ureaplasma urealyticum, and Mycoplasma hominis in Clinical Samples by PCR with Hybridization-Fluorescent Detection

Reagent kit for the simultaneous detection and quantification of DNA from Ureaplasma parvum, Ureaplasma urealyticum, and Mycoplasma hominis in clinical samples using PCR with hybridization-fluorescent detection "AmpliSens® U.parvum / U.urealyticum / M.hominis-screen-titer-FL" according to TU 9398-184-01897593-2011.

The reagent kit is available in one format (FRT) and comes in four configurations:

• Form 1 includes a "PCR kit" variant FRT;
• Form 2 includes "PCR kit" variant FRT, "DNA-sorb-AM" variant 100, and "Transport medium with mucolytic (TMM)" 100 tubes of 0.5 ml each;
• Form 3 includes "PCR kit" variant FRT, "DNA-sorb-AM" variant 100, and "Transport medium for smears" 100 tubes of 0.5 ml each;
• Form 4 includes bulk reagent kits packaged by individual reagents with labeling on their bulk packaging.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Simultaneous Detection and Quantification of DNA from Ureaplasma parvum, Ureaplasma urealyticum, and Mycoplasma hominis in Clinical Samples by PCR with Hybridization-Fluorescent Detection, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.